These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33992440)
1. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients. Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440 [TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Chong PP; Avery RK Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095 [TBL] [Abstract][Full Text] [Related]
3. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports. Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821 [TBL] [Abstract][Full Text] [Related]
4. Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation. Aoki T; Kamimura T; Yoshida S; Mori Y; Kadowaki M; Kohno K; Ishihara D; Urata S; Sugio T; Kamezaki K; Kato K; Ito Y; Eto T; Akashi K; Miyamoto T Biol Blood Marrow Transplant; 2019 Aug; 25(8):1576-1585. PubMed ID: 30959161 [TBL] [Abstract][Full Text] [Related]
5. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review. L'Huillier AG; Kumar D Hum Vaccin Immunother; 2015; 11(12):2852-63. PubMed ID: 26291740 [TBL] [Abstract][Full Text] [Related]
6. Spotting a potential threat: Measles among pediatric solid organ transplantation recipients. Statler VA; Fox T; Ardura MI Pediatr Transplant; 2023 Jun; 27(4):e14502. PubMed ID: 36919399 [TBL] [Abstract][Full Text] [Related]
7. Management and prevention of varicella and measles infections in pediatric solid organ transplant candidates and recipients: An IPTA survey of current practice. Pittet LF; Danziger-Isakov L; Allen UD; Ardura MI; Chaudhuri A; Goddard E; Höcker B; Michaels MG; Van der Linden D; Green M; Posfay-Barbe KM Pediatr Transplant; 2020 Dec; 24(8):e13830. PubMed ID: 32964637 [TBL] [Abstract][Full Text] [Related]
8. Live virus vaccination of pediatric solid organ transplant candidates within 1 month prior to transplantation: A multicenter experience. Rosenthal A; Madigan T; Chen SF; Gans H; Nadimpalli S Transpl Infect Dis; 2021 Aug; 23(4):e13667. PubMed ID: 34145665 [TBL] [Abstract][Full Text] [Related]
10. Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT. Punchhi G; Negus R; Saif H; Pritchard S; Owen O; Sehmbi A; Hamm C Vaccine; 2023 Sep; 41(41):5936-5939. PubMed ID: 37652820 [TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients. Sakuraba A; Luna A; Micic D Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444 [TBL] [Abstract][Full Text] [Related]